Antibacterial activity of lipophilic fluoroquinolone derivatives

Medicinal Chemistry

Volumn 5, Issue 5, 2009, Pages 419-421

  de Almeida, Camila G ^a   Diniz, Cláudio G ^a   Silva, Vânia L ^a   Saraiva, Maurício F ^a   Le Hyaric, Mireille ^a   de Almeida, Mauro V ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Alkyl chains; Antibacterial activity; Diamines; Fluoroquinolones; Gatifloxacin; Lipophilicity; Moxifloxacin

Indexed keywords

GATIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LIPOPHILICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BACTERIA; FLUOROQUINOLONES; HYDROPHOBICITY; MICROBIAL SENSITIVITY TESTS; QUINOLINES;

EID: 70349101688     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340609789117859     Document Type: Article

References (10)

1. Anquetin, G.; Greiner, J.; Mahmoud, N.; Santilhana-Hayat, M.; Gonzalbes, R.; Farhati, K.; Derouin, F.; Aubry, A.; Cambau, E.; Vierling, P. Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp, and Mycobacterium tuberculosis of new 6-fluoroquinolones. Eur. J. Med. Chem., 2006, 41, 1478-1493.
2. Lesher, G.Y.; Froelich, E.D.; Gruet M.D.; Bailey, J.H.; Brundage; R.P. 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J. Med. Pharm. Chem., 1962, 5, 1063-1065.
3. Da Silva, A.D.; De Almeida, M.V.; De Souza, M.V.N.; Couri, M.R.C. Biological activity and synthetic metodologies for the preparation of fluoroquinolones, a class of potent antibacterial agents. Curr. Med. Chem., 2003, 10, 21-39.
4. De Souza, M.V.N.; Vasconcelos, T.R.A.; De Almeida, M.V.; Cardoso, S.H. Fluoroquinolones: an important class of antibiotics against tuberculosis. Curr. Med. Chem., 2006, 13, 455-463.
5. Tobin, C.M.; Sunderland, J.; White, L.O.; MacGowan, A.P.; Reeves, D.S. An isocratic high performance liquid chromatography (HPLC) assay for moxifloxacin, a new 8-methoxyquinolone. J. Antimicrob. Chemother., 1998, 42, 278-279.
6. Woodcock, J.M.; Andrews, J.M.; Boswel, F.J.; Brenwald, N.P.; Wise, R. In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrob. Agents Chemother., 1997, 41, 101-106.
7. Aldridge, K.E.; Ashcraft, D.S. Comparison of the in vitro activity of BAY 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes. Antimicrob. Agents Chemother., 1997, 41, 709-711.
8. Lu, T.; Zhao, X.; Li, X.; Drlica-Wagner, A.; Wang, J-Y.; Domagala, J.; Drlica, K. Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of S. aureus. Antimicrob. Agents Chemother., 2001, 45, 2703-2709.
9. De Almeida, M.V.; Saraiva, M.F.; De Souza, M.V.N.; Da Costa, C.F.; Vicente, F.R.C.; Lourenço, M.C.S. Synthesis and antitubercular activity of lipophilic moxifloxacin and gatifloxacin derivatives. Bioorg. Med. Chem. Lett., 2007, 17, 5661-5664.
10. Alviano, W.S.; Alviano, D.S.; Diniz, C.G.; Antoniolli, A.R.; Alviano, C.S.; Farias, L.M.; Carvalho, M.A.; Souza, M.M.; Bolognese, A.M. In vitro antioxidant potential of medicinal plant extracts and their activities against oral bacteria based on Brazilian folk medicine. Arch. Oral Biol., 2008, 53, 545-552.